Garrido Castillo, L.N.; Mejean, A.; Vielh, P.; Anract, J.; Decina, A.; Nalpas, B.; Benali-Furet, N.; Desitter, I.; Paterlini-Bréchot, P.
Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy. Life 2022, 12, 165.
https://doi.org/10.3390/life12020165
AMA Style
Garrido Castillo LN, Mejean A, Vielh P, Anract J, Decina A, Nalpas B, Benali-Furet N, Desitter I, Paterlini-Bréchot P.
Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy. Life. 2022; 12(2):165.
https://doi.org/10.3390/life12020165
Chicago/Turabian Style
Garrido Castillo, Laura Nalleli, Arnaud Mejean, Philippe Vielh, Julien Anract, Alessandra Decina, Bertrand Nalpas, Naoual Benali-Furet, Isabelle Desitter, and Patrizia Paterlini-Bréchot.
2022. "Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy" Life 12, no. 2: 165.
https://doi.org/10.3390/life12020165
APA Style
Garrido Castillo, L. N., Mejean, A., Vielh, P., Anract, J., Decina, A., Nalpas, B., Benali-Furet, N., Desitter, I., & Paterlini-Bréchot, P.
(2022). Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy. Life, 12(2), 165.
https://doi.org/10.3390/life12020165